General Information of the Compound
Compound ID
CP0966434
Compound Name
(4S,7S,10S,13S,16S,19S,22S,25S,28S,34S,37S,40S,43S,46S,49S,52S,55S,58S,61S)-19-((1H-indol-3-yl)methyl)-61-((2S,8S,11S,14S,17S,20S)-20-amino-14-(4-aminobutyl)-17-sec-butyl-2-(3-guanidinopropyl)-8-(hydroxymethyl)-11-isobutyl-21-methyl-4,7,10,13,16,19-hexaoxo-3,6,9,12,15,18-hexaazadocosanamido)-46-(3-amino-3-oxopropyl)-13-(4-aminobutyl)-37,43-di-sec-butyl-4-carbamoyl-10,52-bis(3-guanidinopropyl)-22-((R)-1-hydroxyethyl)-7,16,25,34-tetrakis(hydroxymethyl)-58-isobutyl-55-isopropyl-2,40,49-trimethyl-28-(2-(methylthio)ethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60-nonadecaoxo-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59-nonadecaazatetrahexacontan-64-oic acid
    Show/Hide
Formula
C131H229N41O36S
Molecular Weight
2986.591
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
    Show/Hide
InChI
InChI=1S/C131H229N41O36S/c1-21-68(14)100(125(205)150-72(18)106(186)169-101(69(15)22-2)127(207)167-90(59-174)108(188)148-57-96(181)152-84(44-50-209-20)115(195)165-93(62-177)122(202)172-103(73(19)178)128(208)162-88(54-74-55-146-76-34-25-24-33-75(74)76)118(198)166-91(60-175)120(200)155-78(35-26-28-45-132)111(191)154-81(39-32-49-145-131(141)142)113(193)164-92(61-176)121(201)159-85(104(136)184)51-63(4)5)170-116(196)82(40-42-94(134)179)153-105(185)71(17)149-109(189)80(38-31-48-144-130(139)140)157-124(204)99(67(12)13)168-119(199)87(53-65(8)9)161-114(194)83(41-43-97(182)183)156-110(190)77(37-30-47-143-129(137)138)151-95(180)56-147-107(187)89(58-173)163-117(197)86(52-64(6)7)160-112(192)79(36-27-29-46-133)158-126(206)102(70(16)23-3)171-123(203)98(135)66(10)11/h24-25,33-34,55,63-73,77-93,98-103,146,173-178H,21-23,26-32,35-54,56-62,132-133,135H2,1-20H3,(H2,134,179)(H2,136,184)(H,147,187)(H,148,188)(H,149,189)(H,150,205)(H,151,180)(H,152,181)(H,153,185)(H,154,191)(H,155,200)(H,156,190)(H,157,204)(H,158,206)(H,159,201)(H,160,192)(H,161,194)(H,162,208)(H,163,197)(H,164,193)(H,165,195)(H,166,198)(H,167,207)(H,168,199)(H,169,186)(H,170,196)(H,171,203)(H,172,202)(H,182,183)(H4,137,138,143)(H4,139,140,144)(H4,141,142,145)/t68-,69-,70-,71-,72-,73+,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,98-,99-,100-,101-,102-,103-/m0/s1
    Show/Hide
InChIKey
UAGASAJLEJWQIF-GARFIVTISA-N
Physicochemical Property
logP
-13.70749
Rotatable Bonds
104
Heavy Atom Count
209
Polar Areas
1281.01
Hydrogen Bond Donor Count
48
Hydrogen Bond Acceptor Count
42
Complexity
209

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4780098
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05999, Relaxin receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  2
1
EC50 = 7585.78 nM
   TI
   LI
   LO
   TS
2
Ki = 2884.03 nM
   TI
   LI
   LO
   TS